A549 cancer cells were pretreated with either U0126 (ERK inhibitor), SP600125 (JNK inhibitor), SB202190 (p38 inhibitor), or wortmannin (PI3K inhibitor) and then exposed to hypoxic conditions. The gene discussed is MAPK14; the disease is cancer.